Semler to Participate in the H.C. Wainwright Global Life Sciences Conference
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
SANTA CLARA, Calif., Feb. 25, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the H.C. Wainwright Global Life Sciences Conference.
The presentation will be available on-demand beginning March 9, at 7:00 am ET and may be accessed through the following link: http://www.semlerscientific.com/hcwr-global. The presentation will be archived for a period of 90 days after the conference. Management will also participate in 1-on-1 calls with investors on March 10 during the conference.
About Semler Scientific, Inc.Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative proprietary products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and U.S. Food and Drug Administration, or FDA, cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at semlerscientific.com.
CONTACT:Susan A. NoonanS.A. Noonan Communicationssusan@sanoonan.com212 966 3650
SOURCE Semler Scientific, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CX Startup Officium Labs Appoints Two Executives, Hits $9M in Revenue
- Ballard Issues Environmental, Social and Governance (ESG) Report 2020
- Team RWB and TRX® Announce New Partnership Supporting Veterans' Health and Wellness